Choose timezone
Your profile timezone:
First International PTCOG Ocular Proton Therapy Symposium 2022
→
Europe/Zurich
Description
Dear colleagues,
We warmly welcome you to the virtual platform for the First International PTCOG Ocular Proton Therapy Symposium 2022.
We are pleased to present thirty-six international experts from radiation oncology, ophthalmology, and radiology to speak on advanced current techniques and future directions for ocular proton/particle radiotherapy.
Recordings of the symposium presentations are now available at our youtube channel.
Working Group responsible for the Symposium preparation
Jan Hrbacek, PhD (PSI, Switzerland), Co-Chair
Andrzej Kacperek, Prof, PhD (UCL, UK), Co-Chair
Kavita K. Mishra, MD MPH (UCSF, USA), Co-Chair
Jan-Willem Beenakker, PhD (LUMC, Netherlands)
Remi Dendale, MD (Institut Curie, France)
Andrea Denker, PhD (HZB, Germany)
Jens Heufelder, PhD (Charité, Germany)
Alejandro Mazal, PhD (CPQ, Spain)
Linda Mortimer, PhD (CCC, UK)
Helen Shih, MD (MGH, USA)
Roelf Slopsema, MSc (Emory, USA)
Contact person
Registration
Registration form
258
/ 270
Participants
258
View full list
-
-
14:00
→
14:10
Welcome
-
14:10
→
15:00
“State of the Art” Treatment Outcomes & Critical Structure DosimetryConvener: Helen Shih (Massachusetts General Hospital)
-
14:10
Introduction to the session “State of the Art” Treatment Outcomes & Critical Structure Dosimetry 3m
-
14:14
Clinical audit of different radiation modalities and different proton beams for ocular tumors 8mSpeaker: Juliette Thariat
-
14:23
Ocular late effects in long term survivors of uveal melanoma in adult and AYA patients treated by proton therapy 8mSpeaker: Alessia Pica (PSI - Paul Scherrer Institut)
-
14:32
Management of ocular side effects following proton beam radiotherapy for uveal melanoma 8mSpeaker: Heinrich Heimann
-
14:41
Navigating Change and Improving Outcomes: Patient-Centered Strategies for the Next Decade 8mSpeaker: Kavita K. Mishra (University of California San Francisco)
-
14:50
Discussion 10m
-
14:10
-
15:00
→
15:10
Break 10m
-
15:10
→
16:10
Ophthalmologist PerspectivesConvener: Kavita K. Mishra (University of California San Francisco)
-
15:10
Introduction to the session Ophthalmologist Perspectives 3m
-
15:14
Ophthalmic advances in proton beam radiotherapy for ocular tumours 8mSpeaker: Bertil Damato
-
15:23
Surgical experience and RT toxicity with a dedicated ocular beamline: Orsay experience 8mSpeaker: Nathalie Cassoux
-
15:32
Best practices from the Chicago Proton Center gantry set-up: Opportunities and Challenges 8mSpeaker: Rashmi Kapur
-
15:41
Surgical best practices and potential pitfalls for proton ocular RT: An ophthalmologist perspective 8mSpeaker: Ann Schalenbourg
-
15:50
Discussion 20m
-
15:10
-
16:10
→
16:20
Break 10m
-
16:20
→
18:30
Dedicated Ocular Beamline & Universal Beamlines Adapted for Ocular TherapyConvener: Andrzej Kacperek (University College London)
-
16:20
Delivery of optimal ocular proton beams in the next decade? 8mSpeaker: Andrzej Kacperek (University College London)
-
16:30
The long-term Nice experience with a dedicated proton eyeline: what can we change without compromising clinical outcomes? 8mSpeaker: Joël Hérault (IMPT-Centre Antoine Lacassagne)
-
16:40
Treating ocular melanoma with a modified pencil-beam-scanning system: a dosimetric study 8mSpeaker: roelf slopsema (Emory University)
-
16:50
Characterization of the non-dedicated scanning proton beamline for ocular treatment and clinical workflow at CNAO 8mSpeaker: MARIO CIOCCA (Fondazione CNAO)
-
17:00
First experience in the Netherlands: Workflow, characterization and multicenter comparison of the HollandPTC ocular beamline 8mSpeaker: Kees Spruijt
-
17:10
Break 10m
-
17:20
Commissioning a commercial eye treatment solution - experience at WPE 8mSpeaker: Benjamin Koska (WPE)
-
17:30
Implementation of Gantry-Based Treatment at the Mayo Clinic: brass-free and auto-gated 8mSpeaker: Amanda Deisher (Mayo Clinic - Rochester)
-
17:40
3-D planning and multi-field treatment without using an ocular beamline 8mSpeaker: William Hartsell (Northwestern Medicine Proton Center)
-
17:48
Round Table Discussion, Future outlook, Q&A 32m
-
18:20
Ocular Proton Therapy Centers Survey 2022 10m
-
16:20
-
14:00
→
14:10
-
-
14:00
→
14:50
2D & 3D Imaging for Treatment PlanningConvener: Jens Heufelder
-
14:00
Introduction to the session 2D & 3D Imaging for Treatment Planning 3m
-
14:04
High resolution MR-imaging for ocular proton therapy planning 8mSpeaker: Jan-Willem Beenakker (Leiden University Medical Center)
-
14:13
MRI evaluation for proton beam treatment planning 8mSpeaker: Berit Verbist (Leiden University Medical Centre)
-
14:22
Strengths and weaknesses of different imaging modalities, an ophthalmologists perspective with focus on treatment planning 8mSpeaker: Antonia Joussen
-
14:31
From clip-based to clipless treatment 8mSpeaker: Jan Hrbacek (PSI - Paul Scherrer Institut)
-
14:40
Discussion 10m
-
14:00
-
14:50
→
15:00
Break 10m
-
15:00
→
16:00
Ocular Treatment Planning Systems Current State and DevelopmentConvener: Mr Jan Hrbacek (PSI - Paul Scherrer Institut)
-
15:00
Introduction to the session Ocular Treatment Planning Systems Current State and Development 3m
-
15:04
EYEPLAN for Proton Radiation Therapy of Ocular Melanoma: UCSF Experience 8mSpeaker: Inder Daftari (University of California- San Francisco)
-
15:13
From EyePlan to Octopus: From model based to 3D planning 8mSpeaker: Jens Heufelder
-
15:22
Experience with the RayOcular TPS – from initial requirements to treated patients at WPE 8mSpeaker: Jörg Wulff
-
15:31
Planning Eye Treatments in a Spot Scanning Gantry with Monte Carlo Calculated Beamlets 8mSpeaker: Jon Kruse
-
15:40
Treatment planning systems for ocular treatment with carbon-ion beams 8mSpeaker: Nobuyuki Kanematsu (National Institutes for Quantum Science and Technology)
-
15:49
Discussion 11m
-
15:00
-
16:00
→
16:10
Break 10m
-
16:10
→
17:10
Patient Set-Up/Delivery and Challenging CasesConvener: Alejandro Mazal
-
16:10
Introduction to the session Patient Set-Up/Delivery and Challenging Cases 3m
-
16:14
Overview of patient set-up and delivery with tips 8mSpeaker: Helen Shih (Massachusetts General Hospital)
-
16:23
A challenging case of a large conjunctival squamous cell carcinoma 8mSpeaker: Roi Dagan
-
16:32
CT based simulation utilizing MRI and scleral clips 8mSpeaker: Lia Halasz (University of Washington)
-
16:41
Proton Re-irradiation for Choroidal Melanomas 8mSpeaker: remi Dendale (INSTITUT CURIE ORSAY)
-
16:50
Eye Tracking technologies for positioning and motion management in Ocular Proton Therapy 8mSpeaker: Riccardo Via (PSI - Paul Scherrer Institut)
-
16:59
Discussion 11m
-
16:10
-
17:10
→
17:20
Break 10m
-
17:20
→
18:20
Dosimetry & QAConvener: roelf slopsema (Emory University)
-
17:20
Introduction to the session Dosimetry & QA 3m
-
17:24
Spatially fractionated proton therapy for eye cancer - Feasibility study 8mSpeaker: Jan Swakon
-
17:33
QA of ocular treatments at Massachusetts General 8mSpeaker: Alexei Trofimov (Massachusetts General Hospital)
-
17:42
In-house developed tools for QA of dedicated ocular beam line 8mSpeaker: Jessica Scholey (University of California San Francisco)
-
17:51
Aspects of the Ocular Quality Assurance Program at the Centre de Protonthérapie d’Orsay 8mSpeaker: Catherine Nauraye
- 18:00
-
18:09
Discussion 11m
-
17:20
-
18:20
→
18:30
Future Directions
-
14:00
→
14:50
